Toxicity studies of Asahi Kasei PI, purified phosphatidylinositol from soy lecithin
スポンサーリンク
概要
- 論文の詳細を見る
Although phosphatidylinositol (PI) is an important component in all plants and animals, there is no toxicity report when purified PI is orally administrated to animals. As a safety evaluation of PI, acute, subchronic and genotoxicity studies were conducted with purified PI from soy lecithin (Asahi Kasei PI). Up to 2,000mg/kg of Asahi Kasei PI was administrated once orally to male and female rats. There were no deaths or any clinical sign in any group throughout the observation period. Then, Asahi Kasei PI was repeatedly administered orally to male and female rats at daily doses of 100, 300 and 1,000mg/kg for 13 weeks. Neither death nor any toxicological signs during the administration period and no changes related to the test substance administered were observed in any group with regard to body weight, food consumption, ophthalmoscopy, hematology, blood biochemistry, necropsy, organ weights or histopathology. Based on these results, the no-observed-adverse effect level (NOAEL) of Asahi Kasei PI was considered to be 1,000mg/kg/day for male and female rats. Genotoxicity evaluation of Asahi Kasei PI was also carried out by the bacterial reverse mutation test (Ames test) and in vitro chromosome aberration test in compliance with the Japanese guidelines on genotoxicity testing of pharmaceuticals, the OECD guidelines for testing chemicals and guidelines for designation of food additives and for revision of standards for use of food additives. The results indicate neither increases of revertant colonies nor chromosome aberration, suggesting that Asahi Kasei PI has high safety in genotoxicity.
- 日本トキシコロジー学会の論文
- 2009-06-01
著者
-
Otsubo Kazumasa
Asahi Kasei Pharma Corporation
-
Honda Kumiko
Department of Toxicology, Panapharm Laboratories Co., Ltd.
-
Yamaguchi Noriko
Bozo Research Center Inc.
-
Nasu Masaaki
Asahi Kasei Pharma Corporation
-
Kamiya Kouichi
Department Of Toxicology Panapharm Laboratories Co. Ltd.
-
Hamamura Masao
Department Of Toxicology Panapharm Laboratories Co. Ltd.
-
Honda Kumiko
Department Of Cardiovascular Medicine Heart Failure Division National Cerebral And Cardiovascular Ce
-
Nakamura Kaori
Bozo Research Center Inc.
-
Oguma Yoshihiro
Bozo Research Center Inc.
-
Fujiwara Sho
Bozo Research Center Inc.
-
Takabe Michihito
Bozo Research Center Inc.
-
Sono Akira
Bozo Research Center Inc.
-
Kawasaki Tsuneshirou
Asahi Kasei Pharma Corporation
-
Wakigawa Koichi
Asahi Kasei Pharma Corporation
-
Enoshima Teruhiko
Department of Toxicology, Panapharm Laboratories Co., Ltd.
-
Oshikata Takafumi
Department of Toxicology, Panapharm Laboratories Co., Ltd.
-
Kamiya Koichi
Department of Toxicology, Panapharm Laboratories Co., Ltd.
-
Oshikata Takafumi
Department Of Toxicology Panapharm Laboratories Co. Ltd.
-
WAKIGAWA Kouichi
Asahi Kasei Pharma Corporation
-
Enoshima Teruhiko
Department Of Toxicology Panapharm Laboratories Co. Ltd.
-
Otsubo Kazumasa
Asahi Kasei Pharma Co.
-
Nasu Masaaki
Asahi Kasei Pharma Co.
関連論文
- Repeated dose toxicity of 2-chlorophenol in newborn rats and comparison with that in young adult rats. (TEST METHODS) (GENERAL SESSION BY POSTER PRESENTATION) (Proceedings of the 30th Annual Meeting)
- Genotoxicity studies of ubidecarenone (coenzyme Q10) manufactured by bacteria fermentation
- Toxicity studies of Asahi Kasei PI, purified phosphatidylinositol from soy lecithin
- MOLECULAR CLONING OF MOUSE LIVER FLAVIN CONTAINING MONOOXYGENASE (FMO1) cDNA AND CHARACTERIZATION OF THE EXPRESSION PRODUCT : METABOLISM OF THE NEUROTOXIN, 1,2,3,4- TETRAHYDROISOQUINOLINE (TIQ)
- Effect of Dietary Phosphatidylinositol on Cholesterol Metabolism in Zucker (fa/fa) Rats
- THIRTEEN-WEEK REPEATED DOSE ORAL TOXICITY STUDY OF COENZYME Q_ IN RATS